FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE and WRONG TECHNIQUE IN DEVICE USAGE PROCESS

2,236 reports of this reaction

2.5% of all FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE reports

#6 most reported adverse reaction

Overview

WRONG TECHNIQUE IN DEVICE USAGE PROCESS is the #6 most commonly reported adverse reaction for FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, manufactured by GlaxoSmithKline LLC. There are 2,236 FDA adverse event reports linking FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE to WRONG TECHNIQUE IN DEVICE USAGE PROCESS. This represents approximately 2.5% of all 88,399 adverse event reports for this drug.

Patients taking FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE who experience wrong technique in device usage process should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

WRONG TECHNIQUE IN DEVICE USAGE PROCESS2,236 of 88,399 reports

WRONG TECHNIQUE IN DEVICE USAGE PROCESS is a less commonly reported adverse event for FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, but still significant enough to appear in the safety profile.

Other Side Effects of FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE

In addition to wrong technique in device usage process, the following adverse reactions have been reported for FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE:

Other Drugs Associated with WRONG TECHNIQUE IN DEVICE USAGE PROCESS

The following drugs have also been linked to wrong technique in device usage process in FDA adverse event reports:

BELIMUMABBUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATEFLUTICASONE FUROATEFLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATEFLUTICASONE PROPIONATE AND SALMETEROLSOMATROPINUMECLIDINIUMUMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE

Frequently Asked Questions

Does FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE cause WRONG TECHNIQUE IN DEVICE USAGE PROCESS?

WRONG TECHNIQUE IN DEVICE USAGE PROCESS has been reported as an adverse event in 2,236 FDA reports for FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is WRONG TECHNIQUE IN DEVICE USAGE PROCESS with FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE?

WRONG TECHNIQUE IN DEVICE USAGE PROCESS accounts for approximately 2.5% of all adverse event reports for FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, making it a notable side effect.

What should I do if I experience WRONG TECHNIQUE IN DEVICE USAGE PROCESS while taking FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE?

If you experience wrong technique in device usage process while taking FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages

FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE Full ProfileAll Drugs Causing WRONG TECHNIQUE IN DEVICE USAGE PROCESSGlaxoSmithKline LLC Drugs
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.